AG
ALBO

Artal Group’s Albireo Pharma Inc ALBO Stock Holding History

Artal Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-600,000
Closed -$14M – 155
2021
Q4 		$14M Hold
600,000
– – 0.38% 59
2021
Q3 		$18.7M Hold
600,000
– – 0.42% 57
2021
Q2 		$21.1M Hold
600,000
– – 0.43% 53
2021
Q1 		$21.1M Sell
600,000
-100,000
-14% -$3.69M 0.37% 60
2020
Q4 		$26.3M Sell
700,000
-151,405
-18% -$5.51M 0.56% 47
2020
Q3 		$28.4M Buy
851,405
+351,045
+70% +$10.2M 0.69% 33
2020
Q2 		$13.3M Sell
500,360
-87,765
-15% -$2.07M 0.37% 59
2020
Q1 		$9.63M Buy
588,125
+137,925
+31% +$3.03M 0.41% 49
2019
Q4 		$11.4M Hold
450,200
– – 0.44% 40
2019
Q3 		$9M Buy
450,200
+200
+0% +$5.18K 0.36% 53
2019
Q2 		$14.5M Sell
450,000
-50,000
-10% -$1.67M 0.59% 38
2019
Q1 		$16.1M Hold
500,000
– – 0.66% 33
2018
Q4 		$12.3M Hold
500,000
– – 0.45% 39
2018
Q3 		$16.5M Hold
500,000
– – 0.43% 35
2018
Q2 		$17.8M Sell
500,000
-47,841
-9% -$1.55M 0.38% 27
2018
Q1 		$17.8M Buy
547,841
+247,841
+83% +$8.35M 0.22% 33
2017
Q4 		$7.68M Buy
+300,000
New +$7.61M 0.12% 55
2013
Q4 		– Sell
-9,691
Closed -$916K – 97
2013
Q3 		$916K Hold
9,691
– – 0.03% 80
2013
Q2 		$1.22M Buy
+9,691
New +$1.01M 0.04% 87

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artal Group's ALBO Position: Q1 2022 in Review

Artal Group sold out of Albireo Pharma Inc (ALBO) in Q1 2022, closing a stake of 600,000 shares — an estimated $14M sold.

Artal Group first reported a position in ALBO in Q2 2013 and held it in 19 quarters. The position peaked at $28.4M in Q3 2020. 109 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

  • Artal Group reported no remaining Albireo Pharma Inc position as of Q1 2022 after selling out during the quarter.
  • Artal Group sold 600,000 Albireo Pharma Inc shares in Q1 2022, an estimated $14M.
  • Artal Group first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 19 quarters.
  • Artal Group's Albireo Pharma Inc position peaked at $28.4M in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Artal Group's 13F filing for Q1 2022, filed 12 May 2022.